John Rogers Jr Purchases 7,500 Shares of Ryan Specialty (NYSE:RYAN) Stock

Ryan Specialty Holdings Inc. (NYSE:RYAN) Director John Rogers, Jr. bought 7,500 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were acquired at an average cost of $35.16 per share, with a total value of $263,700.00. Following the completion of the purchase, the director owned 117,933 shares in the company, valued at approximately $4,146,524.28. This represents a 6.79% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Ryan Specialty Price Performance

Shares of RYAN traded down $0.19 on Thursday, reaching $34.48. The stock had a trading volume of 3,025,129 shares, compared to its average volume of 2,307,542. The firm has a market capitalization of $9.09 billion, a PE ratio of 44.77, a PEG ratio of 0.80 and a beta of 0.64. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 2.90. The firm has a 50-day moving average of $33.56 and a 200 day moving average of $42.03. Ryan Specialty Holdings Inc. has a twelve month low of $29.28 and a twelve month high of $69.49.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.04. The business had revenue of $795.23 million for the quarter, compared to analysts’ expectations of $781.44 million. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The company’s revenue was up 15.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.39 EPS. Sell-side analysts expect that Ryan Specialty Holdings Inc. will post 2.05 EPS for the current year.

Ryan Specialty Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, May 26th. Investors of record on Tuesday, May 12th were issued a $0.13 dividend. The ex-dividend date was Tuesday, May 12th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.5%. Ryan Specialty’s dividend payout ratio is currently 67.53%.

Ryan Specialty announced that its board has authorized a share repurchase program on Tuesday, May 26th that permits the company to repurchase $300.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 3.5% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in RYAN. Royal Bank of Canada lifted its stake in shares of Ryan Specialty by 10.6% during the 1st quarter. Royal Bank of Canada now owns 59,639 shares of the company’s stock worth $4,406,000 after purchasing an additional 5,739 shares during the period. AQR Capital Management LLC lifted its stake in shares of Ryan Specialty by 25.1% during the 1st quarter. AQR Capital Management LLC now owns 4,972 shares of the company’s stock worth $367,000 after purchasing an additional 998 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Ryan Specialty by 46.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock worth $27,787,000 after purchasing an additional 119,055 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Ryan Specialty by 11.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company’s stock worth $24,586,000 after purchasing an additional 33,667 shares during the period. Finally, Creative Planning lifted its stake in shares of Ryan Specialty by 15.4% during the 2nd quarter. Creative Planning now owns 4,586 shares of the company’s stock worth $312,000 after purchasing an additional 613 shares during the period. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on RYAN shares. Weiss Ratings restated a “sell (d+)” rating on shares of Ryan Specialty in a report on Monday, May 4th. JPMorgan Chase & Co. lowered their price target on Ryan Specialty from $49.00 to $43.00 and set an “underweight” rating on the stock in a report on Thursday, April 9th. Royal Bank Of Canada initiated coverage on Ryan Specialty in a report on Tuesday, March 17th. They set an “outperform” rating and a $45.00 target price on the stock. Morgan Stanley lowered their target price on Ryan Specialty from $45.00 to $39.00 and set an “overweight” rating on the stock in a report on Thursday, May 21st. Finally, Wells Fargo & Company cut Ryan Specialty from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $42.00 to $31.00 in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $47.12.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.